Bettering BCG: a tough task for a TB vaccine?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Effect of glycosylation on the affinity of the MTB protein Ag85B for specific antibodies: towards the design of a dual-acting vaccine against tuberculosis.Biology direct · 2024
   Article
2. Heterologous Boosting WithFrontiers in immunology · 2020
   Article
3. Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.Current opinion in immunology · 2017
   Review
4. The Secreted Protein Rv1860 of Mycobacterium tuberculosis Stimulates Human Polyfunctional CD8+ T Cells.Clinical and vaccine immunology : CVI · 2016
   Article
5. Correlation of phenotypic profiles using targeted proteomics identifies mycobacterial esx-1 substrates.Journal of proteome research · 2014
   Article
6. Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis.Current opinion in immunology · 2014
   Review
7. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.Nature · 2014
   Article
8. Harnessing local and systemic immunity for vaccines against tuberculosis.Mucosal immunology · 2014
   Review
9. The ongoing challenge of latent tuberculosis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2014
   Review
10. Unmet needs in respiratory diseases : "You can't know where you are going until you know where you have been"--Anonymous.Clinical reviews in allergy & immunology · 2013
    Review
11. Commentary: Bettering BCG: a tough task for a TB vaccine?Frontiers in immunology
    Article

Corrections and comments

• Commented on by
  Commentary: Bettering BCG: a tough task for a TB vaccine?

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as